4//SEC Filing
Boylan James P 4
Accession 0001104659-25-058935
CIK 0001953926other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:36 PM ET
Size
5.9 KB
Accession
0001104659-25-058935
Insider Transaction Report
Form 4
Boylan James P
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-10+18,500→ 18,500 totalExercise: $11.94Exp: 2035-06-10→ Common Stock (18,500 underlying)
Footnotes (2)
- [F1]The option vests as to 100% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, subject to continued service.
- [F2]The reporting person holds the stock option, and the shares underlying the option, for the benefit of Enavate Sciences, LP. Accordingly, the reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Zenas BioPharma, Inc.
CIK 0001953926
Entity typeother
Related Parties
1- filerCIK 0001953094
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:36 PM ET
- Size
- 5.9 KB